Interest of S100B Protein for Patient Victim of Minor Traumatic Brain Injury and Treated by Antiplatelet

PHASE3RecruitingINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

January 27, 2019

Primary Completion Date

July 27, 2025

Study Completion Date

January 27, 2026

Conditions
Minor Traumatic Brain InjuryTreatment by Antiplatelet
Interventions
BIOLOGICAL

S100B protein dosing

Patients under antiplatelet therapy and who have a minor traumatic brain injury will have a blood samples with protein S100B dosage on arrival to the emergency room and after they will have a brain scanner between 4 and 8 hours after the trauma to analyse the negative predictive value with a treshold of 0.105 μg/L

Trial Locations (4)

34090

RECRUITING

CHU of MONTPELLIER, Montpellier

75013

RECRUITING

La Pité Salpêtrière, Paris

86021

RECRUITING

CHU of POITIERS, Poitiers

06003

NOT_YET_RECRUITING

CHU of NICE, Nice

All Listed Sponsors
lead

Poitiers University Hospital

OTHER